Belgian start-up BIO INX and Carl ROTH partner to expand access to 3D bioprinting solutions

29-Nov-2024 - BIO INX and Carl ROTH announced their new distribution agreement. This collaboration marks Carl ROTH’s first foray into the 3D bioprinting space, as the company continues its strategy of expanding into the rapidly growing 3D printing industry. Through this partnership, Carl ROTH will now offer ...

4Tissue raises €2m to advance groundbreaking breast tissue replacement technology

A revolutionary approach

30-Oct-2024 - 4Tissue, a pioneering biotech company revolutionizing regenerative medicine with its cutting-edge, bioresorbable hydrogel tissue mimic has successfully completed a €2M seed funding round including equity investment and non-dilutive grants. Led by three prominent female investors from the life ...

Epigenetic changes reprogram astrocytes into brain stem cells

Discovery shows that astrocytes could potentially be used in regenerative medicine to replace damaged nerve cells

09-Sep-2024 - Resting brain stem cells hardly differ from normal astrocytes, which support the nerve cells in the brain. How can almost identical cells perform such different functions? The key lies in the methylation of their genetic material, which gives these special astrocytes stem cell properties. ...

Key mechanisms identified for the regeneration of neurons

Researchers have shown how glial cells are reprogrammed into neurons via epigenetic modifications

04-Jul-2024 - Neurological disorders, such as trauma, stroke, epilepsy, and various neurodegenerative diseases, often lead to the permanent loss of neurons, causing significant impairments in brain function. Current treatment options are limited, primarily due to the challenge of replacing lost neurons. Direct ...

Mogrify extends Series A financing to $46 million USD

The Company’s pipeline aims to address degenerative diseases of the eye, ear and pancreas via direct in vivo restoration of clinically valuable cell types

10-Oct-2023 - Mogrify Limited, a biopharmaceutical company transforming the lives of patients through a novel class of in vivo reprogramming therapies, announced an additional $10 million USD closing of its Series A financing, bringing the total raised to $46 million USD in this round. The funding will support ...

Leading the way in regenerative medicine: cell-specific properties of novel spider silk materials

05-May-2023 - Materials made of spider silk can be specifically modified or processed in such a way that living cells of a certain type adhere to them, grow and proliferate. This has been discovered by researchers at the University of Bayreuth under the direction of Prof. Dr. Thomas Scheibel. Cell-specific ...

CO.DON finally saved

Investor has taken over the business operations of the biopharmacy company

27-Jan-2023 - With effect from 20.01.2023, CO.DON's business activities will be continued in the legal form of a GmbH (limited liability company) following a transferring reorganisation. The asset deal with Rejuvenate GmbH, a company of the American-Chinese ReLive Group, concluded in October 2022 as a result ...

A Speed Limit Could Be a Breakthrough for Stem Cell Therapy

Less speed, improved cellular reprogramming

10-Mar-2022 - Replacing sick or damaged cells with healthy cells: this is a major goal of regenerative medicine. One of the most promising approaches is cellular reprogramming, whereby one cell type in our body converts to another cell type. Research carried out at Helmholtz Munich and ...

CSIC researchers develop more effective bioelectrodes for future medical treatments

Study concludes that bioelectrodes with nanocolumns perform better than traditional ones

02-Mar-2022 - The human body uses electricity to emit signals and nerve pulses and, therefore, the application of techniques based on improving this interaction has become of interest in the search for new therapeutic and diagnostic tools for various types of diseases. Thus, bioelectrode techniques have become ...

Harvard University licenses kidney engineering technology to newly launched startup

Powerful combination of 3D bioprinting and stem cell-based tissue engineering could enable new approaches to treating chronic kidney disease

28-Feb-2022 - A newly launched startup is building upon innovations developed over several years at the Wyss Institute for Biologically Inspired Engineering at Harvard University, Harvard John A. Paulson School of Engineering & Applied Sciences (SEAS), and Brigham and Women’s Hospital (Brigham) to engineer ...